InnoMed PredTox Consortium Presents Final Results From Non-clinical Safety Studies

On October 13, 2008 the InnoMed PredTox Consortium, a joint Industry and European Commission collaboration to improve drug safety, will meet in Basel to present conclusions from a 36-month non-clinical safety study. The consortium has been assessing the value of combining results from molecular profiling technologies with results from more conventional toxicology methods for more informed decision making early in the non-clinical safety evaluation of new drug candidates.

Source: Genedata